eisai liaoning
Eisai Acquires Chinese Generics Company Liaoning TianYi
The acquisition of Liaoning gives Eisai a foothold in China’s generics sector which accounts for 80 percent of the country’s pharmaceutical market.
The acquisition of Liaoning gives Eisai a foothold in China’s generics sector which accounts for 80 percent of the country’s pharmaceutical market.
